FDA Adverse Event Malfunction Summary report: N

LENSX LASER SYSTEM

MDR report key: 8184398 · Received December 20, 2018

Report

Report Number
2028159-2018-02663
Event Type
Malfunction
Date Received
December 20, 2018
Date of Event
July 5, 2018
Report Date
January 15, 2019
Manufacturer
ALCON LENSX, INC.
Product Code
OOE
PMA / PMN Number
K163551
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE COMPANY SERVICE REPRESENTATIVE EXAMINED THE SYSTEM AND WAS UNABLE TO CONFIRM OR REPLICATE THE REPORTED EVENT. PARTS WERE REPLACED. IT WAS DETERMINED BY THE COMPANY SERVICE REPRESENTATIVE THAT THE SYSTEM WAS NOT SUITABLE FOR FLAP CREATION, SO THE FLAP MODE WAS DEACTIVATED. THE SYSTEM WAS THEN TESTED AND MET ALL PRODUCT SPECIFICATIONS FOR USE IN LASER ASSISTED CATARACT SURGERY. THE ROOT CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED CONCLUSIVELY. (B)(4).

Additional Manufacturer Narrative · 1

INVESTIGATION, INCLUDING ROOT CAUSE ANALYSIS, IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. BASED ON ASSESSMENT, THE PRODUCT MET SPECIFICATIONS AT THE TIME OF RELEASE. ALCON LENSX (SITE # (B)(4)) IS NO LONGER OPERATIONAL. LENSX MANUFACTURED PRODUCTS ARE MAINTAINED AND INVESTIGATED BY THE ALCON RESEARCH, LTD. IRVINE TECHNOLOGY CENTER (SITE # (B)(4)). THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 1

A CUSTOMER REPORTED AN IRREGULAR FLAP AND A WAVY STROMAL BED FOLLOWING CORNEAL FLAP CREATION OF THE LEFT EYE. THERE ARE TWO RELATED REPORTS FOR THIS PATIENT. THIS REPORT ADDRESSES THE PATIENT'S LEFT EYE, AND ANOTHER MANUFACTURER REPORT WAS PREVIOUSLY FILED FOR THE FELLOW EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1023790 LENSX LASER SYSTEM OPHTHALMIC FEMTOSECOND LASER OOE ALCON LENSX, INC. 550 NA

Patients

Seq Age Sex Outcome Treatment
1